About
Bone Marrow-derived Stem Cells
Areas of Focus
Categories
Biologics & BiopharmaceuticalMidwest
Team (174)
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
5
As Collaborator
6
Total Enrollment
164
By Phase
PHASE1/PHASE2: 3PHASE1: 6
By Status
RECRUITING: 4WITHDRAWN: 3ACTIVE_NOT_RECRUITING: 1TERMINATED: 1UNKNOWN: 1SUSPENDED: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Today
Hover over trial bars to see details
Recent Trials
NCT06752577Collaborator
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
N/ARecruiting
50 participants
Started: Dec 22, 2024 · Completed: Dec 31, 2031
NCT05589896Lead Sponsor
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
PHASE1/PHASE2Recruiting
12 participants
Started: Aug 16, 2024 · Completed: Dec 31, 2026
NCT07145411Lead Sponsor
HPC Offered for PRESERVE Expansion
N/ARecruiting
10 participants
Started: Jun 27, 2024 · Completed: Aug 31, 2029
NCT05900401Collaborator
Delayed Tolerance Through Mixed Chimerism
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Oct 1, 2023 · Completed: Dec 31, 2030
NCT05443464Lead Sponsor
Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD)
PHASE1Withdrawn
Started: Jun 5, 2023 · Completed: Oct 14, 2024
Funding History (1)
D
May 29, 2018
Locations (1)
Headquarters
Indianapolis, IN, United States
Map
Loading map...